Skinvisible, Inc. (SKVI): Net Income
-$1.06M
Year ended 2025-12-31
-$1.03M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.06M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$565.7K | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$2.38M | n/m | 2025-04-14, From 2023-01-01 |
| 2022-12-31 | -$1.22M | n/m | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | -$1.07M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$1.45M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$1.70M | n/m | 2021-04-15, From 2019-01-01 |
| 2018-12-31 | $158.3K | n/m | 2020-05-14, From 2018-01-01 |
| 2017-12-31 | -$1.83M | n/m | 2019-04-15, From 2017-01-01 |
| 2016-12-31 | -$2.05M | n/m | 2018-03-23, From 2016-01-01 |
| 2015-12-31 | -$1.99M | n/m | 2017-04-17, From 2015-01-01 |
| 2014-12-31 | -$1.93M | n/m | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | -$1.34M | n/m | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | -$1.45M | n/m | 2014-04-11, From 2012-01-01 |
| 2011-12-31 | -$1.36M | n/m | 2013-04-16, From 2011-01-01 |
| 2010-12-31 | -$1.07M | n/a | 2012-11-19, From 2010-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$1.06M | n/m |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | -$8.64M | n/m |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$1.56M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$5.02M | n/m |
| Talphera, Inc. (TLPH) | 2025-12-31 | -$14.29M | n/m |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$11.84M | n/m |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | -$274.45M | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$62.15M | n/m |
| Altimmune, Inc. (ALT) | 2025-12-31 | -$88.09M | n/m |
Compare SKVI, JUNS, BDPT, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗